Objective: Children born small for gestational age are at increased risk of developing type 2 diabetes in adulthood. The satiety signal leptin that regulates food intake and energy expenditure might be a possible molecular link, as umbilical cord leptin levels are positively correlated with birth weight. In the present study, we examined whether common single nucleotide polymorphisms (SNPs) in the leptin (LEP; 19G4A) gene and its receptor (LEPR; Q223R and K109R) are associated with birth weight and adult metabolic risk factors for type 2 diabetes in twins. Design: SNPs were genotyped in 396 monozygotic and 232 dizygotic twins (286 men and 342 women, mean age 25 years) recruited from the East Flanders Prospective Twin Survey. Data were analysed using linear mixed models. Results: The LEPR K109R SNP was associated with birth weight (KK, KR and RR (95% confidence interval, CI): 2511 (2465-2557), 2575 (2516-2635) and 2726 (2606-2845) gram; P additive ¼ 0.001). Also the LEPR Q223R SNP showed a significant association with weight at birth (QQ, QR and RR (95% CI): 2492 (2431-2554), 2545 (2495-2595) and 2655 (2571-2740) gram; P additive ¼ 0.003). Furthermore, an interaction between the LEPR K109R and the Q223R SNP on birth weight was observed (P ¼ 0.014). G allele carriers of the LEP 19G4A SNP had higher high-density lipoprotein (HDL) cholesterol levels compared to 19A homozygotes (GX vs AA (95% CI): 1.62 (1.58-1.66) vs 1.49 (1.40-1.58) mmol l À1 ; P recessive ¼ 0.013). Conclusions: This study indicates that leptin may act as a growth-promoting signal during fetal development, and suggests a possible role for the LEPR in explaining the inverse relationship between birth weight and the development of metabolic diseases in adulthood. Additionally, these results suggest that the LEP 19G4A SNP affect HDL cholesterol levels.
Introduction
Many studies have confirmed the association between low birth weight and increased risk of adult diseases like type 2 diabetes. [1] [2] [3] In an attempt to explain this association Hales and Barker 3 proposed the 'thrifty phenotype hypothesis' and argued that insufficient nutrient supply during fetal life would lead to permanent changes of the structure and function of certain organs and tissues. These adaptations would result in an altered metabolic state, which is unfavourable in postnatal life when nutrient supply is abundant. 3 Genetic factors were not included in this hypothesis, even though there is substantial evidence that genetic susceptibility is important in the determination of both birth weight and adult metabolic disorders. 4, 5 Hence, Hattersley and Tooke 6 suggested in the 'fetal insulin hypothesis' that birth weight and type 2 diabetes have common genetic antecedents. This genetically determined insulin resistance may result in low insulin-mediated fetal growth and also in insulin resistance in adulthood. 6 Although the hypothesis is supported by several single gene disorders, 6 the identification of variants that explain the association between low birth weight and type 2 diabetes in the general population is less evident. Molecular factors involved in fetal growth and also in postnatal insulin metabolism are possible candidates for the 'fetal insulin hypothesis'. Leptin is a satiety factor that inhibits food intake and stimulates energy expenditure by acting on the appetite centres in the hypothalamic regions of the brain. 7 Leptin is primarily released by adipocytes and serum levels are highly correlated with adipose tissue mass. The hormone and its receptor are also expressed in other tissues, including pancreatic b-cells where it inhibits insulin secretion. [7] [8] [9] During pregnancy, leptin is produced by maternal and fetal adipose tissue and also by the placenta, and in contrast to maternal leptin levels, umbilical cord leptin levels are positively correlated with birth weight. 10, 11 The association between single nucleotide polymorphisms (SNPs) in the leptin (LEP)/leptin receptor (LEPR) gene and birth weight has not been studied, this in contrast to the large number of (inconclusive) studies on the association with type 2 diabetes and obesity. In this study we therefore examined the effect of common SNPs in LEP and LEPR on birth weight and adult metabolic risk factors for type 2 diabetes measured in young twins recruited from the East Flanders Prospective Twin Survey (EFPTS). The SNPs studied have previously been associated with type 2 diabetesrelated traits in other populations, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] and are either nonsynonymous or located in a region that might be of importance in the regulation of gene expression.
Materials and methods
Study population DNA was available of 628 individuals, including 197 monozygotic (MZ, 89 men and 108 women pairs) and 108 dizygotic (DZ, 33 men, 41 women and 34 mixed pairs) complete twin pairs, and 18 single twins (2 MZ/16 DZ) recruited from the population-based EFPTS. A detailed description of the twin sample has been given elsewhere. 4 Birth weights were obtained from obstetric records, and gestational age reported by the obstetrician was calculated as the number of completed weeks of pregnancy based on the last menstrual period. Maternal body mass index (BMI; before pregnancy) and diabetes status was obtained from a questionnaire filled in by the mother of the twins, who was contacted at the time the twins were invited to the research centre. The methods used to measure the phenotypes at adult age has been described earlier. 4 The Ethics Committee of the Faculty of Medicine of the Katholieke Universiteit Leuven approved the project and all participants gave informed consent.
DNA isolation
Genomic DNA was extracted initially from available placental tissue collected at birth. If placental tissue was unavailable, twin pairs were contacted and whole blood or mouth swabs were taken for DNA extraction. The DNA mini kit (Qiagen, Venlo, the Netherlands) was used for placental and mouth swab DNA extraction, the Wizard kit (Promega, Leiden, the Netherlands) was used for blood DNA extraction, both according to manufacturer's instructions. There is a possibility that placental tissues were switched within twin pairs during collection at birth. As a consequence, genotypes and phenotypes would be combined incorrectly. To avoid false combinations, discordant genotypes within DZ pairs, of whom only DNA extracted from placenta tissue was available, were treated as missing values (less than 7% per SNP).
Genotyping
The LEP 19G4A SNP located in the untranslated exon 1 (in LEP no common non-synonymous SNPs have been identified), the LEPR K109R SNP in exon 4 and LEPR Q223R SNP in exon 6 were genotyped using pyrosequencing technology (Pyrosequencing AB, Uppsala, Sweden 
Statistical analysis
A w 2 -test was used to check for Hardy-Weinberg proportions among genotype frequencies of the SNPs, using only one randomly selected twin per pair (Supplementary Table 1) . HAPLOVIEW was used to calculate linkage disequilibrium between the two SNPs in the LEPR gene. 40 Traits with a skewed distribution were normalized by log transformation.
Differences in means between men and women according to
Common SNPs in LEP and LEPR NY Souren et al zygosity were calculated using the PROC MIXED method implemented in the SAS package (version 9.1, SAS Institute Inc., Cary, NC, USA). A random intercept model was used, where the intercept of each twin pair was modelled as a function of the population intercept plus a unique contribution of the pair. Additionally, the variance-covariance structure of the random intercept was allowed to differ between MZ and DZ pairs. 41 For birth weight the intra-pair correlations differ between MZ monochorionic (MC) and MZ dichorionic (DC) twins. Although data on chorionicity were available, the variance-covariance structure of the random intercept of birth weight was allowed to differ between MZ MC, MZ DC and DZ pairs. Before the association analyses were performed, the effects of potential covariates on all phenotypes were also checked using PROC MIXED. The phenotypes BMI, waist-to-hip ratio (WHR) and sum of four skinfolds (S4SF) were checked for the effect of zygosity, gender and age; body mass, fat mass and lean body mass were checked for the effect of zygosity, gender, age and height; the blood parameters were checked for the effect of zygosity, gender, age and fat (BMI, WHR or S4SF) and birth weight was checked for the effect of gender, chorionicity and gestational age. Covariates were incorporated into the model, when the F-test indicated Po0.10. Subsequently, the genotype was entered in the optimized model and a general association test (no assumption for mode of inheritance) was performed using a two degrees of freedom (d.f.) F-test. If the general association test was significant, then the mode of inheritance was further investigated by testing an additive, dominant and a recessive model using a one d.f. F-test. In case of positive associations, possible SNP-SNP interactions (including interactions between SNPs within the same gene) were tested by including the main effects and the interaction term in the MIXED model.
Multiple testing
Since multiple tests were performed, a principal component factor analysis (PCFA) was carried out on all phenotypes to assess the number of separate hypotheses that were actually tested. The PCFA was performed on residuals adjusted for significant covariates and the number of factors were selected based on the criteria of eigenvalue41.0. To produce interpretable factors, we used an orthogonal varimax rotation, as oblique rotation (that is, oblimin) showed that the inter-factor correlations were low (o0.10). In addition, the factor loadings yielded by oblique rotation were very similar to those produced by the varimax rotation. Variables sharing at least 50% of their variance with a factor, equivalent to a factor loading40.70, were considered as measuring the same construct and were therefore entered into the factor.
In total, six factors were extracted by PCFA (Supplementary Table 2 ). Factor 1 contained lean body mass and four obesity parameters (body mass, BMI, fat mass and S4SF, respectively). Factor 2 showed high loadings for total cholesterol and lowdensity lipoprotein (LDL) cholesterol. Factor 3 contained insulin-like growth factor binding protein-1 (IGFBP-1) and fasting glucose levels, and factor 4 fasting insulin and leptin levels. Factor 5 showed high loadings with HDL cholesterol only, and in factor 6 no traits had a factor loading40.70 (Supplementary Table 2) .
Within each factor, the number of phenotypes (n v ) was summed and to determine the significance threshold for these phenotypes, a Bonferroni correction was performed (a/n v , where a ¼ 0.05). Consequently, the significance threshold applied in the genetic association analysis for body mass, BMI, fat mass, lean body mass and S4SF was 0.01, and for total cholesterol, LDL cholesterol, IGFBP-1, fasting glucose, fasting insulin and leptin levels 0.025. The remaining phenotypes preserved the significance threshold of 0.05 (Supplementary Table 2 ).
Results
Phenotypic characteristics of the twins are summarized by gender in Table 1 . In both MZ and DZ twins, men were taller and heavier and had higher lean body mass, WHR and fasting glucose levels than those in women (Po0.05). On the other hand, fat mass, S4SF, IGFBP-1, fasting insulin, leptin, HDL cholesterol and non-esterified fatty acids (NEFA) levels were lower in men than those in women (Po0.05). In MZ twins only, total cholesterol and triacylglycerol levels were significantly lower in men, and in DZ twins only, men had a higher weight at birth and higher LDL cholesterol levels.
The major allele frequencies of the LEP 19G4A, LEPR K109R and LEPR Q223R SNPs were 0.627, 0.760 and 0.586, respectively, and are similar to those reported in other Caucasian populations (Supplementary Table 1 Table 2 ). In addition, the R allele of the LEPR Q223R SNP was also associated with a higher weight at birth (QQ, QR and RR (95% CI): 2492 (2431-2554), 2545 (2495-2595) and 2655 (2571-2740) gram; P ¼ 0.009) ( Table 2 ). For both the LEPR K109R and the LEPR Q223R SNP, the model assuming an additive mode of inheritance was most significant (P additive ¼ 0.001 and P additive ¼ 0.003, respectively). Between the LEPR SNPs and the adult metabolic risk factors, no significant associations were observed (Supplementary  Tables 3 and 4) .
Because the presence of gestational diabetes might bias our results, we repeated the analysis without subjects of whom Common SNPs in LEP and LEPR NY Souren et al the mother had glycosuria during pregnancy (n ¼ 35 for K109R, n ¼ 33 for Q223R). In addition, 69 subjects were excluded because data on maternal diabetes status was missing. Also after exclusion of these subjects, the association with birth weight remained significant for both the LEPR K109R and the LEPR Q223R SNP (P additive ¼ 0.004 and P additive ¼ 0.01, respectively).
Because maternal BMI is an important predictor of birth weight, 42 we repeated the analysis with maternal BMI as an extra covariate in the model. This resulted in a smaller sample size, because maternal BMI was missing for a number of individuals (n ¼ 105 for K109R, n ¼ 107 for Q223R). However the association between birth weight and the LEPR K109R and the LEPR Q223R SNP remained significant (P additive ¼ 0.007 and P additive ¼ 0.05, respectively). A significant interaction between the LEPR K109R and the LEPR Q223R SNP was observed for birth weight (P ¼ 0.014) (Figure 1) . Subjects with the K109R/R223R or the R109R/ R223R genotype had a significantly higher birth weight than subjects with the LEPR K109K/Q223Q, K109K/Q223R, K109K/R223R, K109R/Q223Q and the K109R/Q223R genotype (0.0006oPo0.05). In addition, subjects with the 
Abbreviations: BMI, body mass index; DZ, dizygotic; HDL, high-density lipoprotein; LDL, low-density lipoprotein; WHR, waist-to-hip ratio; IGFBP1, insulin-like growth factor protein 1; MZ, monozygotic; n, number of individuals; NEFA, non-esterified fatty acids; S4SF, sum of four skinfolds; WHR, waist-to-hip ratio. Data are expressed as mean±s.d. a P-value calculated using standard linear regression, because convergence criteria could not be met in the random intercept model. b Geometric mean±s.d.
Common SNPs in LEP and LEPR NY Souren et al K109R/Q223Q genotype had a significantly lower birth weight compared to subjects with the K109K/Q223Q, K109K/Q223R, K109R/Q223R and R109R/Q223R genotype (0.007oPo0.05) (Figure 1 ). The LEP 19G4A SNP was significantly associated with HDL cholesterol levels (P ¼ 0.02; Table 2 ). Subjects carrying the G allele of LEP had higher HDL cholesterol levels compared to 19A homozygotes (GX vs AA (95% CI): 1.62 (1.58-1.66) vs 1.49 (1.40-1.58) mmol l
À1
; P recessive ¼ 0.013). No significant associations between the LEP SNP and the other metabolic risk factors were observed (Supplementary Table 5 ).
Discussion
In this association study carried out in a young Belgian twin sample, we evaluated the effect of common SNPs in the LEP (19G4A) gene and its receptor (K109R and Q223R) on birth weight and metabolic risk factors for type 2 diabetes measured in adult life.
The coding SNPs K109R and Q223R in the LEPR gene were strongly associated with birth weight; subjects carrying the R allele of the LEPR K109R and/or Q223R SNP had a significantly higher weight at birth. However, the two SNPs were moderately in linkage disequilibrium (D 0 ¼ 0.93 and r 2 ¼ 0.40), suggesting that the observed associations are not completely independent. According to current literature, this is the first study investigating the relation between these LEPR SNPs and birth weight. Rand et al. 43 studied the relation between the Q223R SNP in the maternal LEPR gene and birth weight; fetal birth weight of mothers carrying the R allele tended to be higher in their UK cohort, but this relation was nonsignificant. 43 The functional relevance of the K109R and the Q223R SNP, both located within the extracellular domain of the leptin receptor, is largely unknown. However, the interaction observed in the present study between these two non-synonymous SNPs on birth weight, might indicate that the binding affinity of the leptin receptor varies according to the different genotype groups. Umbilical cord leptin levels are positively correlated with birth weight. 10, 11 Currently, there is no consensus on the significance of this correlation, whether it implies that leptin acts as a growth-promoting signal during fetal development or if it is just a good marker for fetal adiposity. 11 Our results, however, indicate that leptin does have a biologic function during prenatal growth. Interestingly, human subjects with total congenital leptin or a leptin receptor deficiency have a normal weight at birth, but exhibit rapid weight gain accompanied by an increased food intake in the first few months of life. 44, 45 Because in postnatal life leptin regulates food intake by acting on the appetite centres in the hypothalamus, these rare cases indicate that leptin-mediated inhibitory effects on food intake are probably not functional in utero, which has also been demonstrated in near-term ovine fetuses. 46 Accordingly, it is more likely that the effect we observe is a result of peripheral leptin actions, for instance by modifying insulin secretion. During fetal life, insulin is one of the major growth factors and it has been shown that leptin inhibits insulin release in pancreatic b-cells. 6, 8 A possible peripheral effect of leptin during fetal development is further supported by the observation that functional leptin receptors are already expressed in pancreatic islets of fetal rats. 47 Studying the relation between the LEPR SNPs and umbilical cord insulin levels might support the proposed mechanism. The strong relation we observed between the LEPR SNPs and birth weight suggests that the LEPR is a good candidate gene for the 'fetal insulin hypothesis'. Under the assumption that the LEPR K109R and Q223R SNPs are indeed involved in the 'fetal insulin hypothesis' then according to our results, K allele carriers of the K109R SNP and Q allele carriers of the Q223R SNP are at increased risk for type 2 diabetes and obesity. In the present study, K allele carriers of the K109R and Q allele carriers of the Q223R SNP tended to have lower leptin and higher NEFA levels, respectively (see Supplementary Tables 3 and 4 ). These effects did however not reach the significance threshold defined for the general association test and were considered non-significant. The young age of the population and the moderate sample size, may have limited our statistical power to identify small effects. In literature, both alleles of these SNPs have been reported as risk alleles for type 2 diabetes and obesity, and a metaanalytic study reported nonsignificant associations. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] 48 Consequently, additional studies in larger populations need to be carried out, to verify the involvement of these coding LEPR SNPs in the 'fetal insulin hypothesis'.
The G allele of the 19G4A SNP located in the 5 0 -untranslated region of the LEP gene has been associated with both increased and reduced leptin levels and BMI, and a number of studies reported lack of association. [17] [18] [19] [20] [21] [22] Because some studies used either small and/or selected samples and the criteria utilized to classify cases and controls differed largely, the relation between this SNP and type 2 diabetes Greatly increased HDL cholesterol levels have been observed in the severely obese leptin-deficient ob/ob and the leptin receptor-deficient db/db mice. This is in contrast with obese humans and other mouse models for obesity and diabetes that have low or normal HDL cholesterol levels. 49 Functional studies have indicated that the high HDL cholesterol levels in the ob/ob and db/db mice are probably due to a delayed hepatic HDL cholesterol catabolism regulated by leptin. 49 It is striking that we observed association between the LEP 19G4A SNP and HDL cholesterol levels, but not with leptin levels. Lack of association with leptin levels might be due to low power, or might indicate that the LEP 19G4A SNP does not result in changes of LEP expression levels in adipocytes, which are the main source of circulating leptin.
In conclusion, this study provides evidence that leptin acts as a growth-promoting signal during fetal development, and suggests a possible role for the LEPR gene in explaining the inverse relationship between birth weight and the development of adult metabolic disorders.
